Stockreport

Eton Pharmaceuticals Reports Positive Study Results for ET-101 (Topiramate Oral Solution)

Eton Pharmaceuticals, Inc.  (ETON) 
Last eton pharmaceuticals, inc. earnings: 3/5 04:02 pm Check Earnings Report
PDF -Results Demonstrated Bioequivalence to the Currently Approved Oral Solid Formulation -Market for Topiramate in Oral Form is Greater than $800 million Annually [Read more]